PortfoliosLab logoPortfoliosLab logo
ZIVO vs. ELMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZIVO vs. ELMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZIVO Bioscience, Inc. (ZIVO) and Electromed, Inc. (ELMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZIVO achieves a -64.94% return, which is significantly lower than ELMD's 27.34% return. Both investments have delivered pretty close results over the past 10 years, with ZIVO having a 23.62% annualized return and ELMD not far behind at 23.42%.


ZIVO

1D
0.00%
1M
-18.67%
YTD
-64.94%
6M
-67.89%
1Y
-82.28%
3Y*
-42.83%
5Y*
-36.44%
10Y*
23.62%

ELMD

1D
-1.62%
1M
37.69%
YTD
27.34%
6M
31.72%
1Y
76.99%
3Y*
46.60%
5Y*
27.60%
10Y*
23.42%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZIVO vs. ELMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZIVO
ZIVO Bioscience, Inc.
-64.94%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%
ELMD
Electromed, Inc.
27.34%-1.46%170.85%4.00%-19.31%32.52%13.41%69.94%-16.14%56.44%

Correlation

The correlation between ZIVO and ELMD is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

-0.03

Correlation (5Y)
Calculated over the trailing 5-year period

-0.02

Correlation (10Y)
Calculated over the trailing 10-year period

-0.00

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2012

-0.02

Fundamentals

Market Cap

ZIVO:

$11.85M

ELMD:

$320.66M

EPS

ZIVO:

-$2.58

ELMD:

$1.16

PS Ratio

ZIVO:

98.33

ELMD:

4.49

Total Revenue (TTM)

ZIVO:

$119.03K

ELMD:

$71.75M

Gross Profit (TTM)

ZIVO:

$39.21K

ELMD:

$56.28M

EBITDA (TTM)

ZIVO:

-$9.86M

ELMD:

$14.10M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZIVO vs. ELMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZIVO
ZIVO Risk / Return Rank: 1717
Overall Rank
ZIVO Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 2626
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 2626
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 88
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 44
Martin Ratio Rank

ELMD
ELMD Risk / Return Rank: 8282
Overall Rank
ELMD Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
ELMD Sortino Ratio Rank: 8181
Sortino Ratio Rank
ELMD Omega Ratio Rank: 8181
Omega Ratio Rank
ELMD Calmar Ratio Rank: 8585
Calmar Ratio Rank
ELMD Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZIVO vs. ELMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and Electromed, Inc. (ELMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ZIVOELMDDifference
Sharpe ratioReturn per unit of total volatility

-1.93

Sortino ratioReturn per unit of downside risk

-2.56

Omega ratioGain probability vs. loss probability

0.97

1.30

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.88

3.33

-4.20

Martin ratioReturn relative to average drawdown

-1.63

6.74

-8.37

ZIVO vs. ELMD - Sharpe Ratio Comparison

The current ZIVO Sharpe Ratio is -0.47, which is lower than the ELMD Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of ZIVO and ELMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ZIVOELMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.47

1.47

-1.93

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.26

0.60

-0.86

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.02

0.44

-0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.01

0.22

-0.21

Drawdowns

ZIVO vs. ELMD - Drawdown Comparison

The maximum ZIVO drawdown since its inception was -98.52%, which is greater than ELMD's maximum drawdown of -78.65%. Use the drawdown chart below to compare losses from any high point for ZIVO and ELMD.


Loading charts...

Drawdown Indicators


ZIVOELMDDifference

Max Drawdown

Largest peak-to-trough decline

-98.52%

-78.65%

-19.87%

Max Drawdown (1Y)

Largest decline over 1 year

-93.85%

-23.27%

-70.58%

Max Drawdown (3Y)

Largest decline over 3 years

-97.16%

-48.86%

-48.30%

Max Drawdown (5Y)

Largest decline over 5 years

-98.52%

-48.86%

-49.66%

Max Drawdown (10Y)

Largest decline over 10 years

-98.52%

-55.84%

-42.68%

Current Drawdown

Current decline from peak

-90.67%

-5.62%

-85.05%

Average Drawdown

Average peak-to-trough decline

-63.75%

-33.79%

-29.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.41%

11.49%

+38.92%

Volatility

ZIVO vs. ELMD - Volatility Comparison

ZIVO Bioscience, Inc. (ZIVO) has a higher volatility of 51.45% compared to Electromed, Inc. (ELMD) at 26.28%. This indicates that ZIVO's price experiences larger fluctuations and is considered to be riskier than ELMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZIVOELMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

51.45%

26.28%

+25.17%

Volatility (6M)

Calculated over the trailing 6-month period

144.20%

37.43%

+106.77%

Volatility (1Y)

Calculated over the trailing 1-year period

176.32%

52.93%

+123.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

139.16%

46.30%

+92.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,082.76%

52.99%

+1,029.77%

Dividends

ZIVO vs. ELMD - Dividend Comparison

Neither ZIVO nor ELMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ZIVO vs. ELMD - Financials Comparison

This section allows you to compare key financial metrics between ZIVO Bioscience, Inc. and Electromed, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M202220232024202520260
18.58M
(ZIVO) Total Revenue
(ELMD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ZIVO and ELMD have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (51.45%) compared to ELMD (26.28%). In terms of maximum drawdown, ZIVO dropped -98.52% vs ELMD's -78.65%.

ELMD currently has the higher Sharpe Ratio (1.47 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZIVO and ELMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer